(Q52374966)

English

Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime.

scientific article published in July 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime. (English)

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

author name string

T F Goss

1

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

A Forrest

2

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

D E Nix

3

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

C H Ballow

4

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

M C Birmingham

5

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

T J Cumbo

6

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

J J Schentag

7

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

language of work or name

0 references

publication date

1 July 1994

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

28

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

7-8

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

863-868

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

Value of serum tests in combined drug therapy of endocarditis

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

The inhibitory quotient. A method for interpreting minimum inhibitory concentration data

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

Effect of dose and schedule on cefoperazone pharmacodynamics in an in Vitro model of infection in a neutropenic host

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

The mode of action of 4-quinolones and possible mechanisms of resistance

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

Mathematical examination of dual individualization principles. (III): Development of a scoring system for pneumonia staging and quantitation of response to antibiotics: results in cefmenoxime-treated patients

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800707

21 January 2018

Identifiers

10.1177/106002809402800707

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

1 reference

Europe PubMed Central

30 April 2018

http://europepmc.org/abstract/MED/7949501

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52374966&oldid=1251561623"